PGAM
NUVB icon

Princeton Global Asset Management’s Nuvation Bio NUVB Stock Holding History

Princeton Global Asset Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,000
Closed -$18.2K – 691
2024
Q1 		$18.2K Buy
+5,000
New +$9.6K ﹤0.01% 379

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Princeton Global Asset Management's NUVB Position: Q2 2024 in Review

Princeton Global Asset Management sold out of Nuvation Bio (NUVB) in Q2 2024, closing a stake of 5,000 shares — an estimated $18.2K sold.

Princeton Global Asset Management first reported a position in NUVB in Q1 2024 and held it in 1 quarter. The position peaked at $18.2K in Q1 2024. 148 funds tracked by Wall St. Rank hold NUVB as of Q2 2024.

  • Princeton Global Asset Management reported no remaining Nuvation Bio position as of Q2 2024 after selling out during the quarter.
  • Princeton Global Asset Management sold 5,000 Nuvation Bio shares in Q2 2024, an estimated $18.2K.
  • Princeton Global Asset Management first reported a position in Nuvation Bio in Q1 2024 and held it in 1 quarter.
  • Princeton Global Asset Management's Nuvation Bio position peaked at $18.2K in Q1 2024.
  • 148 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2024.

Based on Princeton Global Asset Management's 13F filing for Q2 2024, filed 12 Aug 2024.